ALHCAlignment Healthcare, Inc.
Alignment Healthcare, Inc. (ALHC) is a health care provider and insurer that offers Medicare Advantage plans to older adults, leveraging its expertise in managing care costs to deliver value. The company is set to report its Q3 2026 earnings on October 29, 2026, a critical event that will provide insight into its financial performance and strategic direction. This earnings release is expected to be a pivotal moment for investors, as it will offer a clearer picture of how the company is navigating the complex landscape of health care reimbursement and cost control.
- Curiosity: Alignment Healthcare has been a target of securities fraud investigations, raising questions about its financial transparency and governance.
- Modeling: Scouter has modeled both bull and bear paths for the upcoming earnings release, with a bull target of $16.50 and a bear fallback of $12.50. The bull probability is 50%, indicating a balanced outlook for the event.
- Past Catalysts: Historical earnings releases and regulatory announcements have shown a mixed performance, with some events leading to strong gains and others resulting in sharp declines. This variability underscores the importance of careful analysis and risk management when considering ALHC's future prospects.
The Read
5% on the CMS Final Rate Announcement for CY 2027 but fell 18%.
The schedule
- Thu29Oct
Earnings report with potential guidance for 2027. Historical sector data suggests balanced outcomes with median +6.99% path change.
- Mon11Jan
Industry-wide trends and regulatory updates. Historical general events show 58% bull outcomes for Health Care.
- Tue9Feb
- Mon5Apr
Policy shift impacting healthcare reimbursement. Historical sector volatility shows 90d HV 85.6% (ALHC).
- Thu29Apr
- Thu5Aug
- Tue10Aug
Potential short-term pressure from insider transactions. Historical capital_raise outcomes show 49% bull.
Past
- Mon14Sep
Actual outcome: Bear · $7.95 at outcome
ALHC reported earnings below expectations and issued weaker-than-anticipated guidance, triggering a sharp sell-off. The negative outlook for near-term revenue and margin pressures led to a significant short-term price decline. The move reflects market concerns over the company's ability to meet growth targets in the current quarter. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: -38.5% from 2026-09-14 to 2026-09-28 (~2.1σ vs typical 10d vol). Target date 2026-09-21 reached; move through 2026-09-28 observed. Confidence 95%.
ALHC reported earnings below expectations and issued weaker-than-anticipated guidance, triggering a sharp sell-off. The negative outlook for near-term revenue and margin pressures led to a significant short-term price decline. The move reflects market concerns over the company's ability to meet growth targets in the current quarter. [Market retrospective · Short-Term (6–10 days)] Missed anticipation: -38.5% from 2026-09-14 to 2026-09-28 (~2.1σ vs typical 10d vol). Target date 2026-09-21 reached; move through 2026-09-28 observed. Confidence 95%.
- Thu6Aug
Actual outcome: Bull · $18.14 at outcome
Alignment Healthcare delivered strong Q1 2026 results, reporting net income of over $11 million and EPS of $0.05 that beat consensus estimates. The company demonstrated disciplined growth and margin expansion as Medicare Advantage costs eased, directly addressing market focus on MLR stabilization. These positive fundamental developments aligned perfectly with the bull case expectations for sustained profitability.
- Mon18May
Actual outcome: Bear · $16.03 at outcome
Despite positive mid-May developments—including backing its Q2 outlook with stable medical costs, joining the S&P SmallCap 600, and strengthening its leadership team—Alignment Healthcare failed to generate upward momentum from its conference appearances. Without a major new catalyst to drive the stock higher, shares drifted lower and ultimately broke well below the $16.00 bear floor by early June.
- Thu30Apr
Actual outcome: Bear · $18.27 at outcome
Alignment Healthcare delivered strong Q1 2026 results, turning a profit with an EPS of $0.05 as Medicare Advantage costs eased and margins expanded. Despite these positive headline numbers, the stock experienced a severe post-earnings sell-off, plunging 18.9% by the outcome date and eventually breaching the $16.50 bear floor as the market likely viewed the good news as already priced in following a pre-earnings run-up.
- Mon6Apr
Actual outcome: Bull · $20.92 at outcome
Alignment Healthcare shares held strong above the $18.25 bull target around the time of the CMS Final Rate Announcement for CY 2027. While specific details regarding the rate impact were limited in the immediate news, the stock's elevated price was supported by positive market sentiment highlighting its attractive valuation and profile as a potential leveraged buyout (LBO) target.
- Fri27Feb
Actual outcome: Bear · $18.57 at outcome
Alignment Healthcare reported strong Q4 results, beating the high-end of its guidance across all key metrics and posting a narrower-than-expected loss of $0.05 per share. However, the stock fell 9.1% following the announcement of a massive 13.16 million share secondary public offering by an affiliate of General Atlantic, which pressured shares downward.